How would I know what Kyle told those that bought
How would I know what Kyle told those that bought unregistered shares?
I have no idea what he told Asher and others.
I know what I have read. One posted on da Hub that Kyle told him that the first Melbourne permit was a recovery permit. I have correspondences from another that Kyle essentially said the same thing.
Then there was the FALSE PR about the same permit. Coincident?
The Defendant posted the truth about the permit and Kyle apparently got a lot of heat for what was being posted by him. They went so far as to LIE to the Court regarding the agreement with the state.
But we know Toreson's (Indy 2) company he is a Director of, had their registration REVOKED and settled with the SEC regarding those charges.
There was no hedge. And as you claim, I know nothing. You're the one that claims to have the inside track. You knew about Indy 1 dismissal, now we have Indy 2.
I have no idea what you and others that dump shares of this POS are being told.
But I do know what the public is being told.
And as I posted, most legit companies that do Investor Presentations file the presentation with the SEC.
Next?
1
Seafarer Exploration (SFRX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
An Evolving Workplace Demands Evolving Strategies Look, careers ain't what they used to be—and they shouldn't be. Today’s world is flipping the script on how we work, and Dr. Brandi R. Muñoz is rewriting the book on career development with her SPECS framework. The guy clinging to his outdated Rolodex for advice isn't gonna cut it anymore. "Who Are Your SPECS?...
Continue Reading
Change in Flight: Bird-X Eyes Strategic Growth Well, here's one that might spread its wings wide. Emanuel Doolittle has joined Bird-X, Inc. as Director of Sales and Business Development. Now, let's not beat around the bush — Bird-X isn't a name you'd see thrown around daily stock talks, but it's stirring up interest in the pest control sector without question. Why...
Continue Reading
A Venture into American Retail Goodal, the darling of Korea's skincare scene, is staking its claim at Costco. This is no small feat, my friends. We're talkin' about a brand that's carved out a sweet niche with its Green Tangerine line. Now it's hitching its wagon to one of America's retail behemoths, known for its unique knack in beauty products. From Olive Young to...
Continue Reading
Well, here's a twist in the pickleball world—DUPR and InBody have struck a deal to bring top-notch body composition tech to the ever-expanding universe of pickleballers. They're merging power players from two different worlds to tap into your performance on the court and your wellness off it. Maybe I'm just jaded from too many marketing pitches, but this one could...
Continue Reading
Just when you think the circus of energy utilities couldn't get any more outlandish, PG&E grabs the spotlight once more. Picture this: they've got the megaphone out, threatening to put the brakes on $2 billion in crucial infrastructure investments. Twenty-five thousand customers left hanging, just waiting for their lights to come on. As if that's not enough, PG&E is also...
Continue Reading
Brace for Impact: Payment Processors in Telehealth A new era is brewing in telehealth, with AI coding tools making website creation a breeze for healthcare folks. But here's the kicker: accepting credit cards is not as easy as setting up a snazzy booking page. Take it from Organic Payment Gateways in good ol' Scarborough, Maine, who've decided to toss their hat into this...
Continue Reading
Luxury Vinyl Tiles: A Market on the Rise Well, folks, the flooring game is picking up steam, and luxury vinyl tiles (LVT) are in the spotlight. With consumers and businesses all looking for something durable yet easy on the eyes and wallet, LVT is answering the call. MarketsandMarkets™ reports that this sector is expected to balloon from USD 18.22 billion in 2026 to USD...
Continue Reading
FDA Throws Wrench Into Bright Minds' Plans This ain't the first time a biotech company's dream has hit the skids, but Bright Minds Biosciences (NASDAQ:DRUG) found themselves in the meat grinder when the FDA threw their epilepsy trial plans under the bus. The partial clinical hold wasn't a gentle slap on the wrist, but a gut punch driven by mouse toxicity findings and...
Continue Reading
A New Era for Family Entertainment Centers Forget the traditional FEC with its solitary rides; the future's all about constructing social destinations that blend immersive storytelling and hybrid offerings. Elephant Sculpture Art Co., Ltd. (ESAC) is at the forefront, drawing from their Shanghai WUNPARK project to reimagine the design of these amusement hubs. Set to engage...
Continue Reading
A Banner Quarter for AMETEK Holy smokes, AMETEK has thrown down some numbers for the third quarter of 2026 that would make any seasoned trader sit up and take notice. We’re talking record-breaking across the board: $2.22 billion in sales, marking a whopping 17% increase over last year. Now, that's not just growth—that's rocket fuel. Earnings per share rocketed up with...
Continue Reading
Top 5 Most Recently Viewed Articles
ThredUp Financial Results for the Third Quarter In the recently concluded third quarter, ThredUp Inc. (NASDAQ: TDUP) reported total revenue of $73 million, marking an 11% decline year-over-year. This decline stems from various market factors influencing the resale industry. Revenue Breakdown and Margins The U.S. market alone contributed $61.5 million to the overall...
Continue Reading
Tesla's Declining Sales in Key European Markets Tesla Inc (NASDAQ: TSLA) is facing significant sales declines in several European countries as reported in early 2025. These drops, drastic in some cases, seem to be a reflection of growing consumer dissatisfaction linked to CEO Elon Musk's heightened political involvement. The Impact of Elon Musk's Political Engagement As...
Continue Reading
Dermata Therapeutics and its Recent Stock Performance In a highly competitive market landscape, Dermata Therapeutics Inc. (DRMA) has experienced a significant decline in stock value, recently hitting a 52-week low of $1.28. As a biotechnology company specializing in dermatological treatments, Dermata has encountered considerable challenges over the past year, resulting in...
Continue Reading
Indonesia's Commitment to the Critical Minerals Industry Fastmarkets proudly reveals an important partnership with the Ministry of Investment and Downstream Industry of Indonesia. This collaboration highlights Indonesia's strategy to boost its role in the global supply chain of critical minerals, aiming to support a sustainable economy centered around clean energy...
Continue Reading
Cox Automotive's Innovative Integration with UVeye Cox Automotive is at the forefront of automotive technology, consistently advancing how dealerships operate. In a recent development, they have integrated their distinctive vAuto platform with UVeye. This integration marks a significant milestone in improving vehicle appraisal processes, allowing for greater efficiency...
Continue Reading